Projects funded by the NCN
Evaluation of the immunomodulatory activity of cefazolin as a potential inhibitor of proinflammatory cytokines which bind to the common receptor gamma (CD132), the perspectives of autoimmune diseases treatment.
2014/13/N/NZ7/00258
Keywords:
common receptor gamma autoimmune diseases rheumatoid arthritis cefazolin
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_12: Prevention of human diseases
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Warszawski Uniwersytet Medyczny, Wydział Nauki o Zdrowiu z Oddziałem Pielęgniarstwa, Oddziałem Zdrowia Publicznego i Oddziałem Dietetyki
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM 7 - announced on 2014-03-17
Amount awarded: 100 000 PLN
Project start date (Y-m-d): 2015-02-25
Project end date (Y-m-d): 2018-02-24
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Information in the final report
- Publication in academic press/journals (1)
- Pharmacophore guided discovery of small-molecule interleukin 15 inhibitors.Authors:Barbara Żyżyńska-Granica, Bartosz Trzaskowski, Szymon Niewieczerzał, Sławomir Filipek, Oliwia Zegrocka-Stendel, Małgorzata Dutkiewicz, Piotr Krzeczy nski, Magdalena Kowalewska, Katarzyna KoziakAcademic press:European Journal of Medicinal Chemistry (rok: 2017, tom: 136, strony: 543-547), Wydawca: ElsevierStatus:PublishedDOI:10.1016/j.ejmech.2017.05.034 - link to the publication